GSK 2250665A

Catalog No. A17191

GSK-2250665A是pKi = 9.2的Itk抑制剂,它对Aurora B激酶和Btk(pIC50值分别为6.4和6.5)和一组其他激酶表现出对Itk的选择性。 抑制PBMC中IFNγ的产生。
Catalog Num A17191
M. Wt 459.61
Formula C26H29N5OS
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 1246030-96-5
Synonyms GSK2250665A, GSK-2250665A
SMILES CCC1=CC=C(N=C(NC3=NC(N[C@H]5CC[C@H](O)CC5)=NC(CC4=CC=CC=C4)=C3)S2)C2=C1
GSK-2250665A是pKi = 9.2的Itk抑制剂,它对Aurora B激酶和Btk(pIC50值分别为6.4和6.5)和一组其他激酶表现出对Itk的选择性。 抑制PBMC中IFNγ的产生。
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 21.76 mL 108.79 mL 217.58 mL
0.5 mM 4.35 mL 21.76 mL 43.52 mL
1 mM 2.18 mL 10.88 mL 21.76 mL
5 mM 0.44 mL 2.18 mL 4.35 mL

*The above data is based on the productmolecular weight 459.61. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.